Short-Term Alterations in Thiol–Disulfide Homeostasis Following ERCP: A Prospective Controlled Study Authors: Mehmet Asıl, Yusuf Avcı, Ali Can Erdem, Ramazan Dertli, Murat Bıyık, Muharrem Keskin, Özcan Erel, Salim Neşelioğlu Published: 2026 ABSTRACT AbstractPurposeEndoscopic retrograde cholangiopancreatography (ERCP) is widely used in the management of pancreaticobiliary disorders and may be associated with systemic oxidative stress. Dynamic thiol–disulfide homeostasis, which reflects the balance between reduced and oxidized thiol groups, has emerged as a sensitive indicator of systemic redox status. This study aimed to evaluate alterations in thiol–disulfide homeostasis in patients undergoing ERCP.MethodsIn this observational study, patients undergoing ERCP and control subjects were included. Serum native thiol, total thiol, disulfide levels, and thiol-based ratios were measured using an automated spectrophotometric assay. Baseline demographic and laboratory characteristics were compared between groups. Age-adjusted analyses were performed using analysis of covariance (ANCOVA), and longitudinal changes were evaluated using mixed-effects models.ResultsCompared with controls, patients undergoing ERCP demonstrated significantly lower native thiol and total thiol levels together with higher disulfide concentrations and altered thiol-based ratios. Age-adjusted analyses confirmed significant group effects for native thiol, total thiol, disulfide, and native thiol/total thiol ratio. Longitudinal analyses showed partial increases in reduced thiol parameters after ERCP; however, post-procedural values remained lower than those observed in controls at the 24-h time point. These alterations were observed irrespective of post-ERCP pancreatitis or pancreatic enzyme elevations.ConclusionPatients undergoing ERCP exhibited significant alterations in thiol–disulfide homeostasis, characterized predominantly by depletion of reduced thiol pools. The observed redox imbalance persisted during the early post-procedural period and appeared to be associated with both underlying pancreaticobiliary disease and procedure-related oxidative stress. Further studies are needed to clarify the clinical significance of these findings.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s10620-026-10031-7.Keywords: Endoscopic retrograde cholangiopancreatography, Thiol–disulfide homeostasis, Oxidative stress, Native thiol, Redox balance Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is a commonly used diagnostic and therapeutic technique for pancreaticobiliary disorders. Although highly valuable in clinical practice, ERCP is an invasive procedure and carries the risk of complications, particularly post-ERCP pancreatitis [1, 2]. In addition to recognized complications, endoscopic retrograde cholangiopancreatography (ERCP) involves mechanical manipulation of the biliary and pancreatic ducts, which may be associated with inflammatory and oxidative responses [3]. Oxidative stress occurs when the production of reactive oxygen species overwhelms the body’s antioxidant defenses, playing a central role in tissue damage and inflammation [4]. Among the various markers of oxidative stress, dynamic thiol–disulfide homeostasis has emerged as a particularly sensitive indicator of redox balance. Thiol groups serve as key antioxidant buffers, and their reversible conversion into disulfide bonds is a crucial adaptive response to oxidative stress [5, 6]. Alterations in dynamic thiol–disulfide homeostasis have been reported in a wide range of inflammatory, metabolic, cardiovascular, and systemic diseases, highlighting its role as a sensitive biomarker of oxidative stress and disturbed redox balance [7–12]. Earlier studies examining oxidative stress in the context of ERCP have mostly focused on conventional markers. Some have assessed oxidative changes only in relation to post-ERCP pancreatitis. However, it is still not fully understood how ERCP itself—apart from pancreatitis—affects thiol-based redox homeostasis. Many previous analyses used cross-sectional or unadjusted comparisons. This approach makes it difficult to capture temporal changes within individuals or to separate procedure-related effects from those related to underlying disease [13, 14]. Accordingly, this study aimed to evaluate dynamic thiol–disulfide homeostasis before and after ERCP. We used both cross-sectional comparisons and longitudinal model-based analyses that account for within-subject repeated measurements. A control group was included. We applied linear mixed-effects models and age-adjusted analyses to clarify whether ERCP is associated with measurable short-term changes in thiol-based redox status, and their relationship with post-ERCP pancreatitis and pancreatic enzyme elevation. Materials and Methods Study Design and Population This observational study was conducted at the Department of Gastroenterology of a tertiary university hospital. Adult patients aged 18–90 years were enrolled if they underwent endoscopic retrograde cholangiopancreatography (ERCP) for diagnostic or therapeutic purposes. Enrollment took place consecutively between April 2017 and April 2018. In total, 70 patients undergoing ERCP were initially enrolled in the study. One patient was excluded from baseline comparative analyses because of incomplete pre-procedural laboratory data. Additionally, 61 control subjects without known pancreaticobiliary disease were recruited from the gastroenterology outpatient clinic. The study protocol was approved by the Institutional Ethics Committee (decision no: 2017/903) and conducted in accordance with the Declaration of Helsinki. Inclusion and Exclusion Criteria Patients were eligible for inclusion if they were aged 18 years or older and had undergone ERCP for any clinical reason. Several exclusion criteria were applied. These included acute pancreatitis or acute cholangitis before ERCP, known malignancy, chronic liver disease (including cirrhosis), clinically overt metabolic-associated steatotic liver disease (MASLD), metabolic syndrome, chronic kidney failure, congestive heart failure, autoimmune or rheumatologic disease, and pregnancy. Patients who refused to provide informed consent were also excluded. Accordingly, all pancreatitis episodes evaluated in this study represented post-ERCP pancreatitis. Although chronic pancreatitis was not specified as a predefined exclusion criterion, no patients in the study cohort had a documented diagnosis of chronic pancreatitis. Control Group The control group included individuals who presented with dyspeptic symptoms. No organic gastrointestinal or pancreaticobiliary pathology was identified in these subjects after routine clinical and laboratory evaluation. Blood samples for thiol–disulfide homeostasis measurements were collected only once from each control subject. ERCP Procedure and Clinical Assessment All ERCP procedures were performed by experienced endoscopists. Procedures were performed based on clinical presentation, laboratory abnormalities, and pre-procedural imaging findings, including ultrasonography and/or cross-sectional imaging suggestive of biliary pathology. ERCP was not used as a primary diagnostic modality in this study. Standard side-viewing duodenoscopes were used under appropriate sedation. Various procedural characteristics were recorded prospectively, including procedure duration, number of cannulation attempts, use of guidewire-assisted cannulation, guidewire passage into the pancreatic duct, stone extraction techniques, stent placement, and procedure-related complications. Post-ERCP pancreatitis was defined and graded for severity according to established consensus criteria. Severity grading was based on the Cotton criteria [15]. Mild pancreatitis was defined as a transient elevation of pancreatic enzymes associated with abdominal pain, requiring hospitalization for three days or less. These cases did not involve local or systemic complications. All observed cases met the criteria for mild pancreatitis. They were characterized by temporary pancreatic enzyme elevation, absence of local or systemic complications, and no need for prolonged hospitalization. Standard prophylactic measures for post-ERCP pancreatitis, including rectal nonsteroidal anti-inflammatory drugs, were applied according to institutional practice. Blood Sampling and Laboratory Analysis Venous blood samples were collected from patients undergoing ERCP at two time points: immediately before the procedure (baseline) and 24 h after ERCP. All blood samples were obtained after an overnight fasting period of at least 8 h. Each sample was centrifuged at 4000 rpm for 5 min at 4 C. The serum separated from the samples was then aliquoted and stored at − 80 C until analysis. Serum native thiol and total thiol levels were measured using an automated spectrophotometric method developed by Erel and Neşelioğlu. In this technique, dynamic disulfide bonds in serum samples are first reduced to free functional thiol groups by sodium borohydride. The excess reducing agent is then neutralized with formaldehyde. Total thiol concentrations are subsequently measured using a modified Ellman reagent, while native thiol levels are measured directly. Disulfide concentrations are calculated as half the difference between total thiol and native thiol levels. Derived thiol–disulfide indices were also calculated, including the native thiol/total thiol, disulfide/total thiol, and native thiol/disulfide ratios. All results were expressed in µmol/L. Routine laboratory parameters, including serum amylase and lipase levels, were retrieved from the hospital electronic medical record system. The analytical performance of the assays, including intra- and inter-assay variability, has been previously described in the original method validation studies. Statistical Analysis Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp., Armonk, NY, USA). Continuous variables were presented as mean ± standard deviation or as median (range), depending on their distribution. Categorical variables were summarized as counts and percentages. Normality of continuous variables was checked visually and confirmed by the Shapiro–Wilk test. Baseline demographic and laboratory characteristics were summarized descriptively. Comparisons between control subjects and the pre-ERCP group were performed using independent-samples t tests or Mann–Whitney U tests, as appropriate for the data distribution. Initial comparisons of pre- and post-ERCP thiol–disulfide parameters were first evaluated using paired statistical tests. These included the paired t test or the Wilcoxon signed-rank test, depending on the data. For between-group comparisons, either the independent-samples t test or the Mann–Whitney U test was used as appropriate for the distribution. To account for repeated measurements within subjects, longitudinal changes in thiol–disulfide parameters were analyzed using linear mixed-effects models for repeated measures. In these models, both time (baseline pre-ERCP vs. 24-h post-ERCP) and post-ERCP pancreatitis status were entered as fixed effects. The interaction term (time × pancreatitis) was also tested to evaluate whether temporal changes in thiol parameters differed by pancreatitis status. Subjects were included as random intercepts to account for within-subject correlation. An unstructured covariance matrix was assumed. Model assumptions were evaluated by visual inspection of residual plots. Models were estimated using restricted maximum likelihood (REML). Age-adjusted comparisons of thiol–disulfide homeostasis parameters were performed between ERCP-pre patients, post-ERCP patients, and control subjects using analysis of covariance (ANCOVA), with age included as a covariate. Effect sizes for the ANCOVA models were reported as partial eta squared (η2). Age was included as a covariate based on its known biological relevance in oxidative stress, regardless of its statistical significance. Additionally, multivariable general linear models (ANCOVA framework) were constructed to further adjust for potential confounders, including age, inflammatory markers (CRP, WBC), liver function parameters (AST, ALT, ALP, GGT, and bilirubin), and diagnostic category (e.g., choledocholithiasis, biliary stricture, or other diagnoses). These models were based on available clinical and laboratory variables; body mass index and metabolic factors were not available and therefore could not be included. Correlations between post-ERCP thiol–disulfide parameters and serum amylase and lipase levels were assessed using Pearson correlation analysis. A two-sided p-value < 0.05 was considered statistically significant. Given the exploratory nature of the study and the predefined focus on thiol–disulfide parameters, formal adjustment for multiple comparisons was not applied. The results were interpreted in the context of biological plausibility and consistency across related parameters. Results Study Population and Baseline Characteristics The study cohort consisted of 69 patients undergoing ERCP and 61 control subjects. Baseline demographic and laboratory characteristics of the study population are summarized in Table 1. Compared with controls, patients undergoing ERCP were significantly older and demonstrated significantly higher inflammatory and hepatobiliary laboratory parameters, including CRP, AST, and ALT levels. Native thiol and total thiol concentrations, as well as the native thiol/total thiol ratio, were significantly lower in the pre-ERCP group compared with controls, whereas absolute disulfide levels did not differ significantly between groups. Additional baseline laboratory characteristics of the ERCP cohort are presented in Table 1 (Section B), Table 2. Table 1 Baseline demographic and laboratory characteristics of the study populationSection A Control vs pre-ERCP comparisonVariableControl (n = 61)Pre-ERCP (n = 69)p valueAge, years39.4 ± 14.461.1 ± 17.2 < 0.001Sex (male/female), n24/3725/430.721WBC (× 103/µL)7.30 ± 2.077.93 ± 2.760.142AST, U/L18.4 ± 4.6157.9 ± 188.1 < 0.001ALT, U/L20.5 ± 10.5240.6 ± 281.1 < 0.001CRP, mg/L3.93 ± 5.4325.8 ± 37.7 < 0.001Creatinine, mg/dL0.72 ± 0.120.76 ± 0.200.187Native thiol, µmol/L439.3 ± 51.3229.8 ± 91.4 < 0.001Total thiol, µmol/L480.6 ± 53.8275.4 ± 89.3 < 0.001Disulfide, µmol/L20.6 ± 4.622.8 ± 9.30.087Native thiol / total thiol ratio91.4 ± 1.880.9 ± 12.6 < 0.001Section B Baseline laboratory profile of the ERCP cohortVariablePre-ERCP valueESR, mm/h25.6 ± 16.8ALP, U/L229.3 ± 198.3GGT, U/L371.9 ± 318.4Total bilirubin, mg/dL2.96 ± 2.89Direct bilirubin, mg/dL1.82 ± 2.07Amylase, U/L59.9 ± 27.1Lipase, U/L34.6 ± 32.7Urea, mg/dL32.9 ± 16.7Values are presented as mean ± standard deviation unless otherwise indicated. Section A includes demographic and laboratory variables available in both the control and pre-ERCP groups and was analyzed using independent-samples t tests or chi-square analysis, as appropriate. Section B summarizes additional baseline laboratory parameters available for the ERCP cohort only. Sample sizes may vary slightly between variables because of missing laboratory data. CRP C-reactive protein, ESR erythrocyte sedimentation rate, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, GGT gamma-glutamyl transferase, WBC white blood cell count Baseline demographic and laboratory characteristics of the study population Values are presented as mean ± standard deviation unless otherwise indicated. Section A includes demographic and laboratory variables available in both the control and pre-ERCP groups and was analyzed using independent-samples t tests or chi-square analysis, as appropriate. Section B summarizes additional baseline laboratory parameters available for the ERCP cohort only. Sample sizes may vary slightly between variables because of missing laboratory data. CRP C-reactive protein, ESR erythrocyte sedimentation rate, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, GGT gamma-glutamyl transferase, WBC white blood cell count Table 2Age-adjusted ANCOVA results for thiol–disulfide homeostasis parametersOutcomeF (df)pPartial η2Control (Adjusted mean ± SE)Pre-ERCP (Adjusted mean ± SE)Post-ERCP (Adjusted mean ± SE)Native thiolF(2,193) = 81.44 < 0.0010.458436.2 ± 11.8231.2 ± 10.2270.7 ± 10.3Total thiolF(2,193) = 75.81 < 0.0010.440475.7 ± 11.8277.6 ± 10.2321.4 ± 10.3DisulfideF(2,193) = 5.900.0030.05819.7 ± 1.223.2 ± 1.025.4 ± 1.0Native thiol / total thiol ratioF(2,193) = 15.09 < 0.0010.13591.5 ± 1.480.9 ± 1.382.3 ± 1.3Values are age-adjusted estimated marginal means (± standard error). Age was not a significant covariate in any model (all p > 0.05). ERCP: endoscopic retrograde cholangiopancreatography Age-adjusted ANCOVA results for thiol–disulfide homeostasis parameters Values are age-adjusted estimated marginal means (± standard error). Age was not a significant covariate in any model (all p > 0.05). ERCP: endoscopic retrograde cholangiopancreatography ERCP procedural characteristics, indications, and post-procedural outcomes are summarized in Table 3. Choledocholithiasis was the most common indication for ERCP. Guidewire-assisted cannulation was used in all procedures, and guidewire passage into the pancreatic duct occurred in 22.9% of cases. Post-ERCP complications were observed in 10.0% of patients, with all post-ERCP pancreatitis cases classified as mild according to consensus criteria. Table 3ERCP procedural characteristics, indications, and post-procedural outcomesVariableValueHistory of ERCP, n (%)16 (22.9)History of cholecystectomy, n (%)21 (30.0)Smoking, n (%)7 (10.0)Pre-ERCP indication, n (%) Choledocholithiasis61 (87.1) Biliary stricture6 (8.6) Elevated liver function tests2 (2.9) Biliary leakage due to hydatid cyst1 (1.4)Post-ERCP diagnosis, n (%) Choledocholithiasis35 (50.0) Normal bile ducts22 (31.4) Biliary stricture12 (17.1) Biliary leakage due to hydatid cyst1 (1.4)Procedure duration, min22.1 ± 13.1Papilla naïve, n (%)54 (77.2)Previous ERCP with sphincterotomy, n (%)16 (22.9)Cannulation attempts, median (range)2 (1–15)Cannulation time, min, median (range)1 (1–25)Guidewire-assisted cannulation, n (%)70 (100)Guidewire passage into pancreatic duct, n (%)16 (22.9)Number of guidewire passages into pancreatic duct2.1 ± 1.2Stone extraction technique, n (%) Balloon catheter only52 (74.0) Balloon + basket catheter7 (10.0) Balloon + basket + mechanical lithotripsy3 (4.3)Biliary or pancreatic stent placement, n (%)20 (28.6) Common bile duct17 (85.0) Pancreatic duct3 (15.0)Post-ERCP complications, n (%)7 (10.0) Post-ERCP pancreatitis6 (8.6) Minor bleeding1 (1.4)Severity of post-ERCP pancreatitisMild in all casesValues are presented as mean ± standard deviation, median (range), or number (percentage), as appropriate. Procedural outcomes and complications, including post-ERCP pancreatitis-related abdominal pain and gastrointestinal symptoms, were assessed during the index hospitalization period ERCP procedural characteristics, indications, and post-procedural outcomes Values are presented as mean ± standard deviation, median (range), or number (percentage), as appropriate. Procedural outcomes and complications, including post-ERCP pancreatitis-related abdominal pain and gastrointestinal symptoms, were assessed during the index hospitalization period Age-Adjusted Group Comparisons of Thiol–Disulfide Homeostasis Age-adjusted ANCOVA demonstrated significant group effects for all thiol–disulfide homeostasis parameters (Table 2). Age was not a significant covariate in any model (all p > 0.05), and the assumption of homogeneity of regression slopes was satisfied for all outcomes. Compared with controls, both pre-ERCP and post-ERCP groups showed lower native and total thiol levels. Disulfide levels were higher in the ERCP groups than in controls. Estimated marginal means with 95% confidence intervals are presented in Fig. 1. Thiol–disulfide homeostasis parameters across study groups. A Native thiol, B total thiol, C disulfide, and D native thiol/total thiol ratio are shown as age-adjusted mean values with 95% confidence intervals for control, pre-ERCP, and post-ERCP groups. Overall age-adjusted ANCOVA p values were p < 0.001 for native thiol, p < 0.001 for total thiol, p = 0.003 for disulfide, and p < 0.001 for native thiol/total thiol ratio Native Thiol Levels Native thiol concentrations showed clear differences between groups (Table 2, Fig. 1A). The adjusted mean native thiol levels were highest in controls (436.2 ± 11.8 µmol/L). These levels were much lower in the pre-ERCP group (231.2 ± 10.2 µmol/L). After ERCP, there was a slight increase in native thiol levels (270.7 ± 10.3 µmol/L). In a longitudinal mixed-effects analysis limited to the ERCP group, native thiol levels increased slightly after ERCP. However, age-adjusted ANCOVA results indicated that post-ERCP values were still significantly lower than those of the control group. The overall group effect was highly significant (ANCOVA: F(2,193) = 81.44, p < 0.001; partial η2 = 0.458). Total Thiol Levels Total thiol concentrations showed a pattern similar to native thiol levels (Table 2, Fig. 1B). The control group had the highest adjusted mean total thiol levels (475.7 ± 11.8 µmol/L). In contrast, both the ERCP-pre (277.6 ± 10.2 µmol/L) and ERCP-post groups (321.4 ± 10.3 µmol/L) had significantly lower values. Total thiol levels increased modestly after ERCP when compared to pre-procedural measurements. However, post-ERCP values still remained lower than those seen in controls. The overall group effect was strong (ANCOVA: F(2,193) = 75.81, p < 0.001; partial η2 = 0.440). Disulfide Levels Disulfide concentrations showed significant differences between groups after age adjustment (ANCOVA: F(2,193) = 5.90, p = 0.003; partial η2 = 0.058) (Table 2, Fig. 1C). The adjusted mean disulfide levels were lower in control subjects (19.7 ± 1.2 µmol/L). In contrast, both the pre-ERCP group (23.2 ± 1.0 µmol/L) and the post-ERCP group (25.4 ± 1.0 µmol/L) had higher values. There was no significant difference between pre- and post-ERCP measurements. Native Thiol / Total Thiol Ratio Age-adjusted analysis showed a significant group effect for the native thiol/total thiol ratio (ANCOVA: F(2,193) = 15.09, p < 0.001; partial η2 = 0.135) (Table 2). The adjusted mean ratio was highest in the control group (91.5 ± 1.4). It decreased markedly in the pre-ERCP group (80.9 ± 1.3) and stayed low in the post-ERCP group (82.3 ± 1.3). There was no significant difference between pre- and post-ERCP measurements. Group differences in the native thiol/total thiol ratio are shown in Fig. 1D. Multivariable-adjusted general linear models including age, inflammatory markers (CRP, WBC), liver function parameters (AST, ALT, ALP, GGT, and bilirubin), and diagnostic category as covariates are presented in Table 4. After adjustment, significant group effects remained for native thiol levels (F = 6.129, p = 0.015, partial η2 = 0.049) and total thiol levels (F = 7.973, p = 0.006, partial η2 = 0.062). No significant group effects were observed for disulfide levels (p = 0.107) or the native thiol/total thiol ratio (p = 0.647). Table 4Multivariable-adjusted effects of group on thiol–disulfide parametersOutcomeF (df)p-valuePartial η2Native thiol (SH)6.130.0150.049Total thiol7.970.0060.062Disulfide2.630.1070.021Native thiol / total thiol ratio0.210.6470.002Values represent results from multivariable general linear models adjusted for age, inflammatory markers (CRP, WBC), liver function parameters (AST, ALT, ALP, GGT, bilirubin), and diagnostic category. Effect sizes are presented as partial eta squared (η2). CRP: C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase Multivariable-adjusted effects of group on thiol–disulfide parameters Values represent results from multivariable general linear models adjusted for age, inflammatory markers (CRP, WBC), liver function parameters (AST, ALT, ALP, GGT, bilirubin), and diagnostic category. Effect sizes are presented as partial eta squared (η2). CRP: C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase Longitudinal and Supplementary Analyses Longitudinal changes within the ERCP cohort were further evaluated using linear mixed-effects models. These analyses showed a significant main effect of time, but only for native thiol levels. Post-ERCP pancreatitis did not have a significant effect on any parameter. The pattern of temporal change in thiol–disulfide parameters after ERCP was similar in patients with and without post-ERCP pancreatitis. (see Online Resource 1) Correlation analyses revealed no significant associations between post-ERCP thiol–disulfide parameters and serum amylase or lipase levels. No significant correlations were observed between thiol–disulfide parameters and pancreatic enzyme levels. (see Online Resource 2). Guidewire passage into the pancreatic duct was observed in 16 patients (22.9%). Among these patients, pancreatic duct stenting was performed in 3 cases (18.7%). Discussion In this study, we evaluated dynamic thiol–disulfide homeostasis in patients undergoing ERCP. We used both age-adjusted and longitudinal analytical approaches. Our main finding is that ERCP was associated with a marked alteration in thiol-based redox balance. This is reflected by a significant reduction of reduced thiol pools in patients who need ERCP, with only partial recovery after the procedure. Importantly, this redox imbalance occurred regardless of whether post-ERCP pancreatitis or elevated pancreatic enzymes developed. These findings may reflect a broader procedure- and disease-related oxidative burden, rather than just obvious pancreatic injury. Compared with previous ERCP-related oxidative stress studies that mainly evaluated conventional oxidative biomarkers or focused on post-ERCP pancreatitis, our study separately assessed reduced and oxidized thiol compartments and integrated control-based, within-patient longitudinal, and multivariable analyses. This approach provides a more detailed characterization of short-term thiol–disulfide changes associated with ERCP. Age-adjusted and multivariable analyses showed that both native and total thiol levels were much lower in the pre- and post-ERCP groups compared to controls. These findings may indicate that patients referred for ERCP already have a significant deficit in circulating antioxidant capacity. The deficit most likely reflects the combined oxidative burden from biliary obstruction, inflammation, and systemic stress [16, 17]. In addition, the elevated inflammatory and hepatobiliary laboratory markers observed at baseline further support the presence of a substantial pre-procedural oxidative and inflammatory burden in patients undergoing ERCP. After ERCP, both native and total thiol levels increased slightly, suggesting a partial recovery of the reduced thiol pool. The lack of change in the native thiol/total thiol ratio despite increases in absolute thiol levels further supports the interpretation that this recovery is incomplete. However, post-procedural values remained lower than those observed in control subjects at the 24-h time point. The present findings reflect early post-procedural changes at 24 h and should not be interpreted as evidence of long-term persistence. Importantly, the observed between-group differences at the 24-h time point after multivariable adjustment suggest that these redox alterations are not solely attributable to systemic inflammation, liver dysfunction, or baseline diagnostic heterogeneity. Although age was not a statistically significant covariate, it was retained in the models due to its known potential influence on oxidative stress parameters. This pattern is consistent with previously reported mechanisms of thiol–disulfide imbalance in oxidative stress conditions [18, 19]. In contrast to the dynamic behavior of reduced thiols, disulfide concentrations remained relatively stable. Disulfide levels stayed consistently higher in ERCP patients than in control subjects. Neither disulfide concentrations nor the native thiol/total thiol ratio showed a meaningful trend toward normalization after the procedure. These findings may suggest that the oxidized component of the thiol pool is relatively stable over short periods. It also appears less responsive to a single procedural intervention. Relatively stable disulfide concentrations at 24 h, along with a reduced native thiol/total thiol ratio, indicate incomplete restoration of thiol–disulfide equilibrium. This imbalance is mainly due to depletion of the reduced thiol pool. Similar differences between dynamic reduced thiol pools and more persistent oxidized thiol species have been reported in chronic inflammatory and systemic diseases as typical features of disturbed thiol–disulfide homeostasis [20, 21]. The difference between reduced and oxidized thiol compartments highlights a fundamental aspect of redox regulation. Reduced thiols are a readily available antioxidant reservoir. They can fluctuate quickly in response to oxidative stress. In contrast, disulfide formation usually represents more stable oxidative changes that are not easily reversible [22]. In this context, ERCP may be associated with partial restoration of the availability of reduced thiols. However, it does not significantly affect the proportion of oxidized thiol species. As a result, thiol–disulfide equilibrium is only partially restored. This outcome is mainly due to the incomplete recovery of circulating reduced thiols [20, 23]. Another important observation is that there was no association between thiol–disulfide indices and post-ERCP pancreatitis or pancreatic enzyme elevations. Both age-adjusted ANCOVA and mixed-effects models showed that post-ERCP pancreatitis was not significantly linked to thiol–disulfide parameters. Similar patterns of change over time were seen, regardless of whether patients developed pancreatitis. Additionally, thiol-based redox markers did not show any correlation with serum amylase or lipase concentrations. These results suggest that the observed redox disturbances may not be solely explained by pancreatic injury. Instead, they probably reflect a more general oxidative response to procedural and disease-related stressors [24, 25]. All cases of post-ERCP pancreatitis in this cohort were mild. This finding further supports the interpretation that the observed oxidative shift reflects a broader procedure- and disease-related oxidative burden rather than severe pancreatic inflammation alone. From a clinical perspective, thiol–disulfide imbalance may represent a sensitive indicator of subclinical oxidative stress in patients undergoing ERCP, even in the absence of overt complications or marked pancreatic enzyme elevation. Although the present findings do not establish direct prognostic or therapeutic implications, they may contribute to a better understanding of the systemic biological response associated with ERCP and underlying pancreaticobiliary disease. Future prospective studies are needed to determine whether thiol-based oxidative stress markers may have value in risk stratification, monitoring recovery, or predicting post-procedural outcomes [8, 16, 26]. The use of both age-adjusted ANCOVA and longitudinal mixed-effects modeling adds strength and clarity to these findings. Age adjustment made sure that any differences seen between groups were not due to demographic imbalances. Mixed-effects modeling took into account correlations within the same patient and captured changes over time after ERCP. Notably, these models found a significant time-dependent effect only for native thiol levels. These findings are consistent with the possibility that reduced thiols represent the most dynamically responsive component of thiol–disulfide redox regulation in this clinical context [27, 28]. Several limitations should be noted. The control group consisted of individuals presenting with dyspeptic symptoms rather than completely healthy subjects, which may not fully represent a true baseline oxidative state. Although patients with clinically overt metabolic-associated steatotic liver disease (MASLD) and metabolic syndrome were excluded, body mass index and detailed metabolic parameters were not systematically available for all participants and therefore could not be incorporated into the analyses. Accordingly, residual metabolic confounding cannot be completely excluded, and comparisons between ERCP patients and controls should be interpreted with caution. The study was conducted at a single center with a relatively modest sample size, particularly for subgroup analyses such as post-ERCP pancreatitis, which may limit the generalizability of the findings. A formal sample size calculation was not performed, and the sample size was determined based on the available patient population during the study period. Given the observational design, a causal relationship between ERCP and changes in thiol–disulfide homeostasis cannot be definitively established. Furthermore, thiol–disulfide parameters were assessed at a single post-procedural time point (24 h) and therefore reflect short-term changes without allowing conclusions on long-term persistence. Despite these limitations, the study has several important strengths. The design included both cross-sectional comparisons with a control group and longitudinal measurements within the ERCP cohort. This approach allowed for the evaluation of thiol–disulfide homeostasis both before and after the procedure. Pre- and post-procedural sampling gave valuable insight into dynamic changes in systemic redox balance related to ERCP. In addition, standardized and validated assays were used for thiol–disulfide homeostasis. Rigorous statistical methods—including age-adjusted analyses and mixed-effects modeling—were also applied. These methods helped account for possible confounding factors and variability within subjects. In conclusion, ERCP was associated with alterations in thiol–disulfide homeostasis; however, given the observational design, these findings should be interpreted as associations rather than causal effects. This disturbance is characterized by depletion of reduced thiols, only partial recovery after the procedure, and an ongoing imbalance during the early post-procedural period in thiol redox status. These changes were observed irrespective of post-ERCP pancreatitis and pancreatic enzyme elevations. This may suggest that they reflect a broader oxidative burden from pancreaticobiliary disease and procedural stress, rather than obvious inflammatory complications. Native thiol levels seem to be the most responsive part of this redox system. They may serve as a sensitive marker of ERCP-related oxidative stress. Further studies are needed to clarify the clinical implications of persistent thiol imbalance. More research may also help determine its potential role in monitoring oxidative stress in patients undergoing ERCP. Supplementary Information Below is the link to the electronic supplementary material. Supplementary file1 (PDF 415 KB) Author Contributions M.A. and A.C.E. conceived and designed the study. M.A., Y.A., and R.D. collected the clinical data. M.B. and M.K. contributed to patient management and data acquisition. O.E. and S.N. performed the biochemical analyses. A.C.E. performed the statistical analyses. M.A. and A.C.E. drafted the manuscript. All authors reviewed and approved the final manuscript. Funding Open access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK). No funding was received for conducting this study. Data Availability The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Conflict of interest The authors declare no competing interests. Ethics approval This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Necmettin Erbakan University Institutional Ethics Committee (decision no: 2017/903). Consent to participate Written informed consent was obtained from all individual participants included in the study. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary file1 (PDF 415 KB) Data Availability Statement The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.